ES406820A1 - Process for preparing pharmaceutical compositions for treating tumours - Google Patents

Process for preparing pharmaceutical compositions for treating tumours

Info

Publication number
ES406820A1
ES406820A1 ES406820A ES406820A ES406820A1 ES 406820 A1 ES406820 A1 ES 406820A1 ES 406820 A ES406820 A ES 406820A ES 406820 A ES406820 A ES 406820A ES 406820 A1 ES406820 A1 ES 406820A1
Authority
ES
Spain
Prior art keywords
urea
molar ratio
stage
ratio
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES406820A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES406820A priority Critical patent/ES406820A1/en
Priority to AT789073A priority patent/AT323886B/en
Priority to DE19732345917 priority patent/DE2345917A1/en
Priority to CA180,981A priority patent/CA1025360A/en
Priority to SU7301962273A priority patent/SU584743A3/en
Priority to ZA00737345A priority patent/ZA737345B/en
Priority to FR7333225A priority patent/FR2199984B1/fr
Priority to AU60368/73A priority patent/AU481817B2/en
Priority to DD173619A priority patent/DD109307A5/xx
Priority to CH1334173A priority patent/CH585219A5/xx
Priority to JP48105372A priority patent/JPS49132222A/ja
Priority to DK509673AA priority patent/DK138727B/en
Priority to GB4382973A priority patent/GB1440206A/en
Priority to BE2053067A priority patent/BE804960A/en
Priority to AR250157A priority patent/AR199004A1/en
Priority to NL7312925A priority patent/NL7312925A/xx
Publication of ES406820A1 publication Critical patent/ES406820A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Inorganic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Procedure for obtaining pharmacologically active glucose derivatives, characterized in that - in a first stage, urea is contacted with magnesium sulfate heptahydrate, in a molar ratio of 1: 0.06 -0.5 at a temperature between approximately 10 and 55ºC, mixed and homogenized until the formation of a transparent and viscous paste; - in a second stage, glucose is added to the resulting paste, in a ratio such that the urea: glucose molar ratio is 1: 1, in the presence of distilled water or physiological saline, slowly stirred and left to stand at the same temperature, comprised between 10 and 55ºC; and - in a third stage, potassium iodide is added to the resulting solution in such a proportion that the urea: IK molar ratio is 1: 0.25-1, stirred until complete dissolution and then the solution is acidified to a pH 2-4, by adding benzoic acid in such a ratio that the urea: benzoic acid molar ratio is 1: 0.25-1. (Machine-translation by Google Translate, not legally binding)
ES406820A 1972-09-19 1972-09-19 Process for preparing pharmaceutical compositions for treating tumours Expired ES406820A1 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
ES406820A ES406820A1 (en) 1972-09-19 1972-09-19 Process for preparing pharmaceutical compositions for treating tumours
AT789073A AT323886B (en) 1972-09-19 1973-09-12 METHOD FOR OBTAINING PHARMACOLOGICALLY ACTIVE GLYCOSIC PREPARATIONS
DE19732345917 DE2345917A1 (en) 1972-09-19 1973-09-12 PROCESS FOR THE PRODUCTION OF PHARMACOLOGICALLY ACTIVE GLYCOSE DERIVATIVES
CA180,981A CA1025360A (en) 1972-09-19 1973-09-14 Process for preparing pharmaceutical compositions for treating tumours
SU7301962273A SU584743A3 (en) 1972-09-19 1973-09-14 Method of preparing glucose
ZA00737345A ZA737345B (en) 1972-09-19 1973-09-17 Process for preparing pharmaceutical compositions for treating tumours
FR7333225A FR2199984B1 (en) 1972-09-19 1973-09-17
AU60368/73A AU481817B2 (en) 1972-09-19 1973-09-17 Process for preparing pharmaceutical compositions for treating tumours
DD173619A DD109307A5 (en) 1972-09-19 1973-09-17
CH1334173A CH585219A5 (en) 1972-09-19 1973-09-18
JP48105372A JPS49132222A (en) 1972-09-19 1973-09-18
DK509673AA DK138727B (en) 1972-09-19 1973-09-18 Process for the preparation of pharmacologically active glucose derivatives for the treatment of tumors, degeneration and inflammation.
GB4382973A GB1440206A (en) 1972-09-19 1973-09-18 Process for preparing pharmaceutical compositions for treating tumours
BE2053067A BE804960A (en) 1972-09-19 1973-09-18 PREPARATION OF GLUCOSE DERIVATIVES WITH PHARMACOLOGICAL PROPERTIES
AR250157A AR199004A1 (en) 1972-09-19 1973-09-19 PROCEDURE TO OBTAIN ACTIVE PHARMACOLOGICAMETNE GLUCOSE DERIVATIVES
NL7312925A NL7312925A (en) 1972-09-19 1973-09-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES406820A ES406820A1 (en) 1972-09-19 1972-09-19 Process for preparing pharmaceutical compositions for treating tumours

Publications (1)

Publication Number Publication Date
ES406820A1 true ES406820A1 (en) 1975-10-16

Family

ID=8462206

Family Applications (1)

Application Number Title Priority Date Filing Date
ES406820A Expired ES406820A1 (en) 1972-09-19 1972-09-19 Process for preparing pharmaceutical compositions for treating tumours

Country Status (15)

Country Link
JP (1) JPS49132222A (en)
AR (1) AR199004A1 (en)
AT (1) AT323886B (en)
BE (1) BE804960A (en)
CA (1) CA1025360A (en)
CH (1) CH585219A5 (en)
DD (1) DD109307A5 (en)
DE (1) DE2345917A1 (en)
DK (1) DK138727B (en)
ES (1) ES406820A1 (en)
FR (1) FR2199984B1 (en)
GB (1) GB1440206A (en)
NL (1) NL7312925A (en)
SU (1) SU584743A3 (en)
ZA (1) ZA737345B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2688689B2 (en) * 1992-04-22 1997-12-10 日本エヌエスシー株式会社 Cold seal adhesive composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149033A (en) * 1961-02-06 1964-09-15 Universal Drug And Res Lab Inc Method of administering aldohexoseurea hypoglycemic compounds to animals

Also Published As

Publication number Publication date
SU584743A3 (en) 1977-12-15
NL7312925A (en) 1974-03-21
DK138727C (en) 1979-04-02
FR2199984B1 (en) 1976-10-22
DE2345917A1 (en) 1974-04-04
CH585219A5 (en) 1977-02-28
DD109307A5 (en) 1974-11-05
CA1025360A (en) 1978-01-31
DK138727B (en) 1978-10-23
FR2199984A1 (en) 1974-04-19
ZA737345B (en) 1975-04-30
AT323886B (en) 1975-08-11
BE804960A (en) 1974-03-18
AU6036873A (en) 1975-03-20
JPS49132222A (en) 1974-12-18
AR199004A1 (en) 1974-07-31
GB1440206A (en) 1976-06-23

Similar Documents

Publication Publication Date Title
ATE5125T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING SANGUINARIA AND GALANGAL FOR THE TREATMENT OF PERIODONTITIS AND TUMORS.
GB1510999A (en) Pharmaceutical preparation in the form of a foil having an active substance incorporated therein
ES370058A1 (en) PROCEDURE FOR THE PREPARATION OF EFFERVESCENT PHARMACEUTICAL COMPOSITIONS.
ES399609A1 (en) Preparation of an acidified milk product in powder form
GB1325400A (en) Process for pruducing 5-iodo-2,-deoxy-uridine
GB1346014A (en) Derivatives of alpha-ketoglutaric acid and their preparation
ES335998A2 (en) Procedure for the preparation of therapeutically active sulfonated derivatives of p-dihydroxybenzene. (Machine-translation by Google Translate, not legally binding)
ES451880A1 (en) Toothpaste compostion
ES419913A1 (en) Antiinflammatory compositions
IT975318B (en) PHOTOSENSITIVE MATERIAL PARTICULARLY FOR PHOTOTECHNICS
ES2195023T3 (en) CRYSTAL IRON-DEXTRAN PREPARATION PROCEDURE.
ES412246A1 (en) Hair shampoos
SE427276B (en) PROCEDURE FOR PREPARING D-HOMOSTEROIDS
ES401603A1 (en) X-ray contrast agents
ES402085A1 (en) PROCEDURE FOR OBTAINING A PLASMA SUBSTITUTE, FREE OF PYROGEN.
ES407420A1 (en) Procedure for the preparation of pyridoxine ascorbate. (Machine-translation by Google Translate, not legally binding)
GB1284156A (en) A method of producing a 2,2-dialkyl-2,3-dihydro-benzo-1,3-oxazone-4
GB1440206A (en) Process for preparing pharmaceutical compositions for treating tumours
ES415452A1 (en) Procedure for the preparation of N-ethyl-2-pirrolylllymehyl-2-metoxy-5-etisulfonyl-benzamide. (Machine-translation by Google Translate, not legally binding)
ES364551A1 (en) Procedure for the preparation of (-) norescopolamine and its salts (Machine-translation by Google Translate, not legally binding)
ES404517A1 (en) Procedure for the preparation of new steroid compounds (Machine-translation by Google Translate, not legally binding)
GB845024A (en) Improvements in or relating to the production of jellies
GB1338812A (en) Norbornene derivatives
ES296176A1 (en) A new compound of hydrogiretinic acid of drug activity and its manufacturing procedure (Machine-translation by Google Translate, not legally binding)
GB1492180A (en) Pharmaceutical composition for the treatment of hyperammoniemia